Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity

Journal of Periodontology

Volumn 75, Issue 10, 2004, Pages 1302-1308

  Carrozzo, Marco ^a   Cozzani, Emanuele ^b   Broccoletti, Roberto ^a   Carbone, Mario ^a   Pentenero, Monica ^a   Arduino, Paolo ^a   Parodi, Aurora ^b   Gandolfo, Sergio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Antigens; Bullous; Gingival diseases; Mouth diseases; Mucous membrane; Pemphigoid

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; BULLOUS SKIN DISEASE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KERATINOCYTE; MALE; MOUTH CAVITY; MOUTH DISEASE; MOUTH LESION; SEROLOGY; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; GINGIVAL DISEASES; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KERATINOCYTES; MALE; MIDDLE AGED; MOUTH DISEASES; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PEMPHIGOID, BULLOUS; RETROSPECTIVE STUDIES; SKIN;

EID: 8744288672     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.10.1302     Document Type: Article

References (29)

1. Scully C, Carrozzo M, Gandolfo S, et al. Update on mucous membrane pemphigoid. A heterogeneous immune-mediated subepithelial blistering entity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:56-68.
2. Chan LS, Yancey KB, Hammerberg C, et al. Immune-mediated subepithelial blistering diseases of mucous membranes. Arch Dermatol 1993;129:448-455.
3. Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002;138:370-379.
4. Nisengard RJ, Neiders M. Desquamative lesions of the gingiva. J Periodontol 1981;52:500-510.
5. Laskaris G, Angelopoulos A. Cicatricial pemphigoid: Direct and indirect immunofluorescent studies. Oral Surg Oral Med Oral Pathol 1981;51:48-54.
6. Fine JD, Neises GR, Katz SI. Immunofluorescence and immunoelectron microscopic studies in cicatricial pemphigoid. J Invest Dermatol 1984;82:39-43.
7. Manton SL, Scully C. Mucous membrane pemphigoid: An elusive diagnosis? Oral Surg Oral Med Oral Pathol 1988;66:37-40.
8. Ahmed AR, Colon JE. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: Effects on disease progression in patients nonresponsive to dapsone therapy. Arch Dermatol 2001;137: 1181-1189.
9. Kelly SE, Wojnarowska F. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Br J Dermatol 1988;118:31-40.
10. Sarret Y, Hall R, Cobo LM, et al. Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies. J Am Acad Dermatol 1991;24:952-958.
11. Bernard P, Prost C, Lecerf V, et al. Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol 1990;94:630-635.
12. Mobini N, Nagarwalla N, Ahmed AR. Oral pemphigoid; subset of cicatricial pemphigoid? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:37-43.
13. Setterfield J, Shirlaw PJ, Kerr-Muir M, et al. Mucous membrane pemphigoid: A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol 1998;138:602-610.
14. Gammon WR, Briggaman RA, Inman AO 3rd, et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984;82:139-144.
15. Cozzani E, Kanitakis J, Nicolas JF, et al. Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus. Arch Dermatol Res 1994;286:295-299.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
17. Pas HH, Kloosterhuis GJ, de Jong MC, Jonkman MF. False-negative results in immunoblot assay of serum IgA antibodies reactive with the 180-kDa bullous pemphigoid antigen: The importance of primary incubation temperature. Br J Dermatol 2001;145:986-989.
18. Schmidt E, Skrobek C, Kromminga A, et al. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol 2001;145:778-783.
19. Egan CA, Yancey KB. The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease. Eur J Dermatol 2000;10:585-589.
20. Leverkus M, Schmidt E, Lazarova Z, et al. Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases? Arch Dermatol 1999;135:1091-1098.
21. Caproni M, Calzolari A, Giomi B, et al. IL-4, IL-5, TGF-beta1 and IFN-gamma mRNAs detected by a new in situ amplification system in cicatricial pemphigoid. Exp Dermatol 2002;11:421-427.
22. Murakami H, Nishioka S, Setterfield J, et al. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid. J Dermatol Sci 1998; 17:39-44.
23. Hashimoto T, Han-Yaku H, Higashiyama M, et al. Four Japanese patients with cicatricial pemphigoid showing both IgG and IgA antibodies against the 180 kDa bullous pemphigoid antigen. Br J Dermatol 1997;137:305-306.
24. Egan CA, Taylor TB, Meyer LJ, et al. The immunoglobulin A antibody response in clinical subsets of mucous membrane pemphigoid. Dermatology 1999;198:330-335.
25. Leonard JN, Wright P, Williams DM, et al. The relationship between linear IgA disease and benign mucous membrane pemphigoid. Br J Dermatol 1984;110:307-314.
26. Leverkus M, Bhol K, Hirako Y, et al, Cicatricial pemphigoid with circulating autoantibodies to beta 4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol 2001;145:998-1004.
27. Bhol KC, Goss L, Kumari S, et al. Autoantibodies to human alpha 6 integrin in patients with oral pemphigoid. J Dent Res 2001;80:1711-1715.
28. Setterfield J, Theron J, Vaughan RW, et al. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol 2001;145:406-414.
29. Carrozzo M, Fasano ME, Broccoletti R, et al. HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity. Br J Dermatol 2001;145:805-808.